TipRanks
Go Ultimate55% OFF

Kuros Biosciences (KURN) Balance Sheet

Kuros Biosciences Balance Sheet

Kuros Biosciences's total assets for Q2 2026 were $120.15M, an increase of 12.06% from the previous quarter. CH:KURN total liabilities were $48.15M for the fiscal quarter, a 19.52% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 107.21M$ 84.54M$ 71.46M$ 82.95M$ 91.34M
$ 40.28M$ 25.79M$ 14.75M$ 14.09M$ 14.36M
$ 66.93M$ 58.75M$ 56.71M$ 68.86M$ 76.98M

Currency in CHF

Kuros Biosciences Debt to Assets

040M80M120M0 %15 %30 %45 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets